Prostate Cancer - Results from #27300

Utilization trends in prostate cancer therapy - Abstract August 17, 2011

Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens - Abstract August 17, 2011

False-positive screening results in the European Randomized Study of Screening for Prostate Cancer - Abstract August 17, 2011

Preoperative prediction of neurovascular bundle involvement of localized prostate cancer by combined T2 and diffusion-weighted imaging of magnetic resonance imaging, number of positive biopsy cores, and Gleason score - Abstract August 17, 2011

Randomised clinical trial: Preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer - Abstract August 17, 2011

A phase II clinical trial of neoadjuvant ketoconazole and docetaxel chemotherapy before radical prostatectomy in high risk patients - Abstract August 17, 2011

Methods of developing UWIN, the modified American Urological Association symptom score - Abstract August 17, 2011

Post-prostatectomy incontinence during sexual activity: A single center prevalence study - Abstract August 17, 2011

Prostate specific antigen velocity per prostate volume: A novel tool for prostate biopsy prediction - Abstract August 17, 2011

Calypso Medical sponsors the great prostate cancer challenge race series in five cities August 17, 2011

Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: Support for the prostate saturation theory - Abstract August 16, 2011

High-intensity focused ultrasound (HIFU): Our experience in the treatment of prostate cancer relapsing after radiotherapy - Abstract August 16, 2011

Coronary artery revascularization and the risk of death in men with prostate cancer - Abstract August 16, 2011

SEER coding standards result in underestimation of positive surgical margin incidence at radical prostatectomy: Results of a systematic audit - Abstract August 16, 2011

Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population - Abstract August 16, 2011

Integrated safety data from 4 randomized, double-blind, controlled trials of autologous cellular immunotherapy with sipuleucel-T in patients with prostate cancer - Abstract August 16, 2011

Quadriplex model enhances urine-based detection of prostate cancer - Abstract August 16, 2011

Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: An insight for oncologists - Abstract August 16, 2011

Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer - Abstract August 16, 2011

Editor's Commentary - Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy August 16, 2011

Page 1366 of 1436